Aromatase Inhibitors for PCT Aromasin, Arimidex, and Arimistane

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

Pre clinical studies have found that SREBP1 and FASN, and lipid metabolism more broadly, may play key roles in the acquisition of resistance to aromatase inhibitors in ILC 123, raising the possibility of targeted therapies to prevent resistance